• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . SepsEast Registry indicates high mortality associated with COVID-19 caused acute respiratory failure in Central-Eastern European intensiv

tetano

Editor, Senior Moderator
Sci Rep


. 2022 Sep 1;12(1):14906.
doi: 10.1038/s41598-022-18991-2.
SepsEast Registry indicates high mortality associated with COVID-19 caused acute respiratory failure in Central-Eastern European intensive care units


Jan Benes[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Miłosz Jankowski[SUP] #[/SUP][SUP] 4 5 [/SUP], Konstanty Szułdrzynski[SUP] 4 5 [/SUP], Roman Zahorec[SUP] 6 [/SUP], Mitja Lainscak[SUP] 7 8 [/SUP], Zoltán Ruszkai[SUP] 9 [/SUP], Matej Podbregar[SUP] 8 10 [/SUP], Jan Zatloukal[SUP] 1 2 [/SUP], Jakub Kletecka[SUP] 1 2 [/SUP], Krzysztof Kusza[SUP] 11 [/SUP], Jakub Szrama[SUP] 11 [/SUP], Estera Ramic[SUP] 12 [/SUP], Katarina Galkova[SUP] 13 [/SUP], Stefan Krbila[SUP] 14 [/SUP], Josef Valky[SUP] 15 [/SUP], Jaka Ivanic[SUP] 16 [/SUP], Marko Kurnik[SUP] 10 [/SUP], Angéla Mikó[SUP] 9 [/SUP], Tamás Kiss[SUP] 17 [/SUP], Barbara Hetényi[SUP] 17 [/SUP], Peter Hegyi[SUP] 18 19 20 [/SUP], Alan Sustic[SUP] 21 22 [/SUP], Zsolt Molnar[SUP] 23 24 25 [/SUP]



Affiliations

Abstract

The coronavirus disease (COVID-19) pandemic caused unprecedented research activity all around the world but publications from Central-Eastern European countries remain scarce. Therefore, our aim was to characterise the features of the pandemic in the intensive care units (ICUs) among members of the SepsEast (Central-Eastern European Sepsis Forum) initiative. We conducted a retrospective, international, multicentre study between March 2020 and February 2021. All adult patients admitted to the ICU with pneumonia caused by COVID-19 were enrolled. Data on baseline and treatment characteristics, organ support and mortality were collected. Eleven centres from six countries provided data from 2139 patients. Patient characteristics were: median 68, [IQR 60-75] years of age; males: 67%; body mass index: 30.1 [27.0-34.7]; and 88% comorbidities. Overall mortality was 55%, which increased from 2020 to 2021 (p = 0.004). The major causes of death were respiratory (37%), cardiovascular (26%) and sepsis with multiorgan failure (21%). 1061 patients received invasive mechanical ventilation (mortality: 66%) without extracorporeal membrane oxygenation (n = 54). The rest of the patients received non-invasive ventilation (n = 129), high flow nasal oxygen (n = 317), conventional oxygen therapy (n = 122), as the highest level of ventilatory support, with mortality of 50%, 39% and 22%, respectively. This is the largest COVID-19 dataset from Central-Eastern European ICUs to date. The high mortality observed especially in those receiving invasive mechanical ventilation renders the need of establishing national-international ICU registries and audits in the region that could provide high quality, transparent data, not only during the pandemic, but also on a regular basis.
 
Back
Top Bottom